Exposure |
Outcome |
MR |
MR |
MR |
MR |
|
|
Methods |
Beta |
OR (95%CI) |
P value
|
IBD |
AA |
MR PRESSO |
-0.06 |
0.94(0.88,1.00) |
0.100 |
|
|
Mr raps |
-0.06 |
0.94(0.83,1.06) |
0.320 |
CD |
AA |
MR PRESSO |
-0.03 |
0.97(0.90,1.05) |
0.488 |
|
|
Mr raps |
/ |
/ |
/ |
UC |
AA |
MR PRESSO |
-0.06 |
0.94(0.88,1.01) |
0.139 |
|
|
Mr raps |
-0.06 |
0.94(0.83,1.06) |
0.336 |
RA |
AA |
MR PRESSO |
-0.04 |
0.96(0.92,1.01) |
0.146 |
|
|
Mr raps |
-0.04 |
0.96(0.91,1.01) |
0.117 |
SLE |
AA |
MR PRESSO |
-0.01 |
0.99(0.96,1.02) |
0.593 |
|
|
Mr raps |
-0.01 |
0.99(0.96,1.03) |
0.691 |
PSO |
AA |
MR PRESSO |
-0.01 |
0.99(0.94,1.04) |
0.678 |
|
|
Mr raps |
0.00 |
1.00(0.94,1.05) |
0.870 |
AA |
IBD |
MR PRESSO |
0.04 |
1.04(0.99,1.09) |
0.154 |
|
|
Mr raps |
0.04 |
1.04(0.97,1.11) |
0.273 |
AA |
CD |
MR PRESSO |
0.06 |
1.06(0.97,1.16) |
0.207 |
|
|
Mr raps |
0.06 |
1.06(0.95,1.18) |
0.290 |
AA |
UC |
MR PRESSO |
0.02 |
1.02(0.96,1.08) |
0.529 |
|
|
Mr raps |
0.02 |
1.02(0.95,1.10) |
0.613 |
AA |
RA |
MR PRESSO |
0.06 |
1.06(1.01,1.11) |
0.019 |
|
|
Mr raps |
0.06 |
1.06(1.00,1.12) |
0.034 |
AA |
SLE |
MR PRESSO |
-0.03 |
0.97(0.88,1.07) |
0.561 |
|
|
Mr raps |
-0.04 |
0.96(0.87,1.07) |
0.453 |
AA |
PSO |
MR PRESSO |
0.01 |
1.01(0.95,1.08) |
0.691 |
|
|
Mr raps |
0.01 |
1.01(0.94,1.09) |
0.791 |